Immunotherapies in chronic immune-mediated neuropathies
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性，不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
C Briani, A Visentin
Handbook of Clinical Neurology, 2026
Elsevier
Steroids and immunoglobulins, either intravenous or subcutaneous, have represented the cornerstone treatment of chronic immune-mediated neuropathies for many years. In the last decade, new therapeutic targets are being studied, with the potential to selectively dampen aberrant immune responses, including drugs that act both on the complement pathways and the recycling mechanism of IgG immunoglobulins by the neonatal receptor (FcRn). Among the latter, efgartigimod has recently been approved for the treatment of chronic inflammatory …
